{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T05:11:30Z","timestamp":1788844290940,"version":"build-2803163510"},"reference-count":129,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["GR-2019\\u201312370173"],"award-info":[{"award-number":["GR-2019\\u201312370173"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031478","name":"NextGenerationEU","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005874","name":"Universita degli Studi Gabriele d'Annunzio Chieti Pescara","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005874","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.psychres.2025.116697","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T06:03:50Z","timestamp":1755497030000},"page":"116697","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Endocannabinoids, depression, and treatment resistance: Perspectives on effective therapeutic interventions"],"prefix":"10.1016","volume":"352","author":[{"given":"Ilenia","family":"Rosa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo Pio","family":"Padula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Semeraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlotta","family":"Marrangone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7261-5659","authenticated-orcid":false,"given":"Antonio","family":"Inserra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"De Risio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Boffa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3626-8928","authenticated-orcid":false,"given":"Francesca","family":"Zoratto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7496-6383","authenticated-orcid":false,"given":"Marta","family":"Borgi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0807-6005","authenticated-orcid":false,"given":"Roberto","family":"Guidotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0576-4064","authenticated-orcid":false,"given":"Giorgio Di","family":"Lorenzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"D\u2019Addario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4164-3040","authenticated-orcid":false,"given":"Mauro","family":"Pettorruso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Martinotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2025.116697_bib0001","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.jpsychires.2022.04.037","article-title":"Real-world effectiveness of ketamine in treatment-resistant depression: a systematic review & meta-analysis","volume":"151","author":"Alnefeesi","year":"2022","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.psychres.2025.116697_bib0002","series-title":"Diagnostic and Statistical Manual of Mental Disorders, DSM-5-TR. ed","year":"2022"},{"key":"10.1016\/j.psychres.2025.116697_bib0003","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3389\/fnins.2016.00243","article-title":"CB2 cannabinoid receptor as potential target against alzheimer\u2019s disease","volume":"10","author":"Aso","year":"2016","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.psychres.2025.116697_bib0004","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.brs.2017.10.015","article-title":"Responders to rTMS for depression show increased fronto-midline theta and theta connectivity compared to non-responders","volume":"11","author":"Bailey","year":"2018","journal-title":"Brain Stimul."},{"key":"10.1016\/j.psychres.2025.116697_bib0005","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1517\/14728222.12.11.1347","article-title":"The cannabinoid CB1 receptor and the endocannabinoid anandamide: possible antidepressant targets","volume":"12","author":"Bambico","year":"2008","journal-title":"Expert. Opin. Ther. Targets."},{"key":"10.1016\/j.psychres.2025.116697_bib0006","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.phrs.2016.07.024","article-title":"The endocannabinoid system and post traumatic stress disorder (PTSD): from preclinical findings to innovative therapeutic approaches in clinical settings","volume":"111","author":"Berardi","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.psychres.2025.116697_bib0007","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1006\/bbrc.1999.0254","article-title":"Brain regional distribution of endocannabinoids: implications for their biosynthesis and biological function","volume":"256","author":"Bisogno","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.psychres.2025.116697_bib0008","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.neuropharm.2015.10.034","article-title":"BDNF \u2013 a key transducer of antidepressant effects","volume":"102","author":"Bj\u00f6rkholm","year":"2016","journal-title":"Neuropharmacology."},{"key":"10.1016\/j.psychres.2025.116697_bib0009","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1038\/cdd.2015.11","article-title":"The CB1 cannabinoid receptor signals striatal neuroprotection via a PI3K\/Akt\/mTORC1\/BDNF pathway","volume":"22","author":"Bl\u00e1zquez","year":"2015","journal-title":"Cell Death. Differ."},{"key":"10.1016\/j.psychres.2025.116697_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2024.115967","article-title":"Alterations in plasma endocannabinoid concentrations among individuals with major depression treated with electroconvulsive therapy","volume":"337","author":"Bloemhof-Bris","year":"2024","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psychres.2025.116697_bib0011","doi-asserted-by":"crossref","first-page":"5526","DOI":"10.3390\/ijms23105526","article-title":"Modulation of endocannabinoid system components in depression: pre-clinical and clinical evidence","volume":"23","author":"Bright","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.psychres.2025.116697_bib0012","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1017\/S1461145708009309","article-title":"A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression","volume":"11","author":"Brunoni","year":"2008","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.psychres.2025.116697_bib0013","doi-asserted-by":"crossref","DOI":"10.1017\/S1462399409000957","article-title":"Emerging role of the cannabinoid receptor CB2 in immune regulation: therapeutic prospects for neuroinflammation","volume":"11","author":"Cabral","year":"2009","journal-title":"Expert. Rev. Mol. Med."},{"key":"10.1016\/j.psychres.2025.116697_bib0014","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/sj.bjp.0707584","article-title":"CB2 receptors in the brain: role in central immune function","volume":"153","author":"Cabral","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.psychres.2025.116697_bib0015","doi-asserted-by":"crossref","DOI":"10.3389\/fncir.2021.768571","article-title":"A glimpse into the sexual dimorphisms in major depressive disorder through epigenetic studies","volume":"15","author":"Cahill","year":"2021","journal-title":"Front. Neural Circuits."},{"key":"10.1016\/j.psychres.2025.116697_bib0016","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00213-017-4771-x","article-title":"Psilocybin with psychological support for treatment-resistant depression: six-month follow-up","volume":"235","author":"Carhart-Harris","year":"2018","journal-title":"Psychopharmacology. (Berl)"},{"key":"10.1016\/j.psychres.2025.116697_bib0017","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.neuron.2012.09.020","article-title":"Endocannabinoid signaling and synaptic function","volume":"76","author":"Castillo","year":"2012","journal-title":"J. Neuron."},{"key":"10.1016\/j.psychres.2025.116697_bib0018","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/YCO.0000000000000562","article-title":"Cannabinoids and the endocannabinoid system in anxiety, depression, and dysregulation of emotion in humans","volume":"33","author":"Chadwick","year":"2020","journal-title":"Curr. Opin. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116697_bib0019","first-page":"172","article-title":"Transcranial magnetic stimulation: a review of its evolution and current applications. Ind","volume":"27","author":"Chail","year":"2018","journal-title":"Psychiatry J."},{"key":"10.1016\/j.psychres.2025.116697_bib0020","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.euroneuro.2023.04.011","article-title":"Esketamine in treatment-resistant depression patients comorbid with substance-use disorder: a viewpoint on its safety and effectiveness in a subsample of patients from the REAL-ESK study","volume":"74","author":"Chiappini","year":"2023","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.psychres.2025.116697_bib0021","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1001\/jamapsychiatry.2016.2586","article-title":"Toward an evidence-based, operational definition of treatment-resistant depression: when enough is enough","volume":"74","author":"Conway","year":"2017","journal-title":"JAMa Psychiatry"},{"key":"10.1016\/j.psychres.2025.116697_bib0022","first-page":"31","article-title":"Exploring the endocannabinoid system: from circadian rhythms to sleep regulation and potential therapeutic insights","volume":"1","author":"D\u2019Angelo","year":"2024","journal-title":"J. Sleep Sleep Disord. Res."},{"key":"10.1016\/j.psychres.2025.116697_bib0023","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.neuroscience.2014.01.049","article-title":"Anandamide activation of CB1 receptors increases spontaneous bursting and oscillatory activity in the thalamus","volume":"265","author":"Dasilva","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.psychres.2025.116697_bib0024","doi-asserted-by":"crossref","first-page":"8127","DOI":"10.1523\/JNEUROSCI.1683-10.2010","article-title":"Brain-derived neurotrophic factor controls cannabinoid CB1 receptor function in the striatum","volume":"30","author":"De Chiara","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.psychres.2025.116697_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.jad.2018.10.117","article-title":"Role of palmitoylethanolamide (PEA) in depression: translational evidence. Translational evidence","volume":"255","author":"De Gregorio","year":"2019","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psychres.2025.116697_bib0026","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jad.2023.10.112","article-title":"Staying connected: an umbrella review of meta-analyses on the push-and-pull of social connection in depression","volume":"345","author":"De Risio","year":"2024","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psychres.2025.116697_bib0027","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1080\/15622975.2020.1851052","article-title":"A clinical approach to treatment resistance in depressed patients: what to do when the usual treatments don\u2019t work well enough?","volume":"22","author":"Dodd","year":"2021","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116697_bib0028","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1097\/JCP.0000000000000973","article-title":"Possible interactions between 5-ht2a receptors and the endocannabinoid system in humans: preliminary evidence of interactive effects of ayahuasca and endocannabinoids in a healthy human subject","volume":"38","author":"Dos Santos","year":"2018","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.psychres.2025.116697_bib0029","doi-asserted-by":"crossref","first-page":"e2834","DOI":"10.1002\/hup.2834","article-title":"Effects of ayahuasca on the endocannabinoid system of healthy volunteers and in volunteers with social anxiety disorder: results from two pilot, proof-of-concept, randomized, placebo-controlled trials","volume":"37","author":"Dos Santos","year":"2022","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.psychres.2025.116697_bib0030","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1007\/s11064-018-2591-y","article-title":"Effects of rTMS on hippocampal endocannabinoids and depressive-like behaviors in adolescent rats","volume":"43","author":"Fang","year":"2018","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.psychres.2025.116697_bib0031","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.bbr.2012.04.019","article-title":"Long-lasting effects of chronic rTMS to treat chronic rodent model of depression","volume":"232","author":"Feng","year":"2012","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.psychres.2025.116697_bib0032","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/1550059419876807","article-title":"Brainwaves oscillations as a potential biomarker for major depression disorder risk","volume":"51","author":"Fern\u00e1ndez-Palleiro","year":"2020","journal-title":"Clin. EEG. Neurosci."},{"key":"10.1016\/j.psychres.2025.116697_bib0034","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.jpain.2017.12.002","article-title":"The involvement of the endocannabinoid system in the peripheral antinociceptive action of ketamine","volume":"19","author":"Ferreira","year":"2018","journal-title":"J. Pain."},{"key":"10.1016\/j.psychres.2025.116697_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.rbp.2012.07.003","article-title":"The endocannabinoid system and its role in schizophrenia: a systematic review of the literature","volume":"34","author":"Ferretjans","year":"2012","journal-title":"Braz. J. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116697_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.ynstr.2021.100304","article-title":"Circulating endocannabinoids and prospective risk for depression in trauma-injury survivors","volume":"14","author":"Fitzgerald","year":"2021","journal-title":"Neurobiol. Stress."},{"key":"10.1016\/j.psychres.2025.116697_bib0037","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/s41398-018-0239-y","article-title":"Gamma oscillations as a biomarker for major depression: an emerging topic","volume":"8","author":"Fitzgerald","year":"2018","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116697_bib0038","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.biopsych.2023.11.016","article-title":"Repetitive transcranial magnetic stimulation\u2013induced neuroplasticity and the treatment of psychiatric disorders: state of the evidence and future opportunities","volume":"95","author":"Fitzsimmons","year":"2024","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116697_bib0039","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0231700","article-title":"Pharmacological treatment of depression: a systematic review comparing clinical practice guideline recommendations","volume":"15","author":"Gabriel","year":"2020","journal-title":"PLoS. One"},{"key":"10.1016\/j.psychres.2025.116697_bib0040","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00213-006-0397-0","article-title":"Hippocampal glutamate concentration predicts cerebral theta oscillations during cognitive processing","volume":"187","author":"Gallinat","year":"2006","journal-title":"Psychopharmacology. (Berl)"},{"key":"10.1016\/j.psychres.2025.116697_bib0041","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.3390\/biom10111575","article-title":"Cannabidiol: a potential new alternative for the treatment of anxiety, depression, and psychotic disorders","volume":"10","author":"Garc\u00eda-Guti\u00e9rrez","year":"2020","journal-title":"Biomolecules."},{"key":"10.1016\/j.psychres.2025.116697_bib0042","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1007\/s11064-024-04117-9","article-title":"Fatty acid amide hydrolase and cannabinoid receptor type 1 genes regulation is modulated by social isolation in rats","volume":"49","author":"Girella","year":"2024","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.psychres.2025.116697_bib0043","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1089\/can.2022.0072","article-title":"CB1 receptor silencing attenuates ketamine-induced hyperlocomotion without compromising its antidepressant-like effects","volume":"8","author":"Gobira","year":"2023","journal-title":"Cannabis. Cannabinoid. Res."},{"key":"10.1016\/j.psychres.2025.116697_bib0044","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1089\/can.2023.0246","article-title":"Endocannabinoids and stress-related neurospsychiatric disorders: a systematic review and meta-analysis of basal concentrations and response to acute psychosocial stress","volume":"9","author":"Gowatch","year":"2024","journal-title":"Cannabis. Cannabinoid. Res."},{"key":"10.1016\/j.psychres.2025.116697_bib0045","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.neuron.2023.10.027","article-title":"CB1R dysfunction of inhibitory synapses in the ACC drives chronic social isolation stress-induced social impairments in male mice","volume":"112","author":"Guo","year":"2024","journal-title":"Neuron"},{"key":"10.1016\/j.psychres.2025.116697_bib0047","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.bbr.2014.08.003","article-title":"Genetic variability in the human cannabinoid receptor 1 is associated with resting state EEG theta power in humans","volume":"274","author":"Heitland","year":"2014","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.psychres.2025.116697_bib0048","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1471-4159.2007.04688.x","article-title":"Electroconvulsive shock treatment differentially modulates cortical and subcortical endocannabinoid activity","volume":"103","author":"Hill","year":"2007","journal-title":"J. Neuroch."},{"key":"10.1016\/j.psychres.2025.116697_bib0049","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.tips.2009.06.006","article-title":"The therapeutic potential of the endocannabinoid system for the development of a novel class of antidepressants","volume":"30","author":"Hill","year":"2009","journal-title":"Trends. Pharmacol. Sci."},{"key":"10.1016\/j.psychres.2025.116697_bib0050","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/2045-5380-3-19","article-title":"Translational evidence for the involvement of the endocannabinoid system in stress-related psychiatric illnesses","volume":"3","author":"Hill","year":"2013","journal-title":"Biol. Mood. Anxiety. Disord."},{"key":"10.1016\/j.psychres.2025.116697_bib0051","doi-asserted-by":"crossref","first-page":"3795","DOI":"10.2174\/13816128113196660735","article-title":"Endocannabinoid signaling in the etiology and treatment of major depressive illness","volume":"20","author":"Hillard","year":"2014","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.psychres.2025.116697_bib0052","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.3892\/mmr.2016.5585","article-title":"Endocannabinoid system: role in depression, reward and pain control (Review)","volume":"14","author":"Huang","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.psychres.2025.116697_bib0053","doi-asserted-by":"crossref","first-page":"586","DOI":"10.3390\/cells10030586","article-title":"The endocannabinoid system and PPARs: focus on their signalling crosstalk, action and transcriptional regulation","volume":"10","author":"Iannotti","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.psychres.2025.116697_bib0054","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1124\/pharmrev.120.000056","article-title":"Psychedelics in psychiatry: neuroplastic, immunomodulatory, and neurotransmitter mechanisms","volume":"73","author":"Inserra","year":"2021","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.psychres.2025.116697_bib0055","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/bph.15977","article-title":"Effects of repeated lysergic acid diethylamide (LSD) on the mouse brain endocannabinoidome and gut microbiome","volume":"180","author":"Inserra","year":"2023","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.psychres.2025.116697_bib0056","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s43556-024-00205-y","article-title":"Treatment-resistant depression: molecular mechanisms and management","volume":"5","author":"Kajumba","year":"2024","journal-title":"Mol. Biomed."},{"key":"10.1016\/j.psychres.2025.116697_bib0057","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.neuron.2020.05.015","article-title":"Targeting homeostatic synaptic plasticity for treatment of mood disorders","volume":"106","author":"Kavalali","year":"2020","journal-title":"Neuron"},{"key":"10.1016\/j.psychres.2025.116697_bib0058","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3389\/fnmol.2020.00125","article-title":"Cannabinoids, endocannabinoids and sleep","volume":"13","author":"Kesner","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.psychres.2025.116697_bib0059","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.108717","article-title":"Ketamine-induced antidepressant like effects in mice: a possible involvement of cannabinoid system","volume":"112","author":"Khakpai","year":"2019","journal-title":"Biomed. PharmacOther"},{"key":"10.1016\/j.psychres.2025.116697_bib0060","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1192\/bjp.2021.37","article-title":"Electroconvulsive therapy for depression: 80 years of progress","volume":"219","author":"Kirov","year":"2021","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116697_bib0061","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.pnpbp.2015.10.010","article-title":"Endocannabinoid CB1 receptor activation upon global ischemia adversely impact recovery of reward and stress signaling molecules, neuronal survival and behavioral impulsivity","volume":"66","author":"Knowles","year":"2016","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116697_bib0062","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s00406-017-0789-7","article-title":"Electroconvulsive therapy enhances endocannabinoids in the cerebrospinal fluid of patients with major depression: a preliminary prospective study","volume":"267","author":"Kranaster","year":"2017","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.psychres.2025.116697_bib0063","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s00406-019-01086-x","article-title":"The novel seizure quality index for the antidepressant outcome prediction in electroconvulsive therapy: association with biomarkers in the cerebrospinal fluid","volume":"270","author":"Kranaster","year":"2020","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"20","key":"10.1016\/j.psychres.2025.116697_bib0064","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.1111\/bph.13250","article-title":"Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor","volume":"172","author":"Laprairie","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.psychres.2025.116697_bib0065","doi-asserted-by":"crossref","first-page":"8867","DOI":"10.1038\/s41598-021-87840-5","article-title":"Peripheral endocannabinoid serum level in association with repetitive transcranial magnetic stimulation (rTMS) treatment in patients with major depressive disorder","volume":"11","author":"Lazary","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.psychres.2025.116697_bib0066","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/bs.vh.2016.10.004","article-title":"BDNF and hippocampal synaptic plasticity","volume":"104","author":"Leal","year":"2017","journal-title":"Vitam. Horm."},{"key":"10.1016\/j.psychres.2025.116697_bib0067","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.biopsych.2016.05.005","article-title":"Glutamate and gamma-aminobutyric acid systems in the pathophysiology of major depression and antidepressant response to ketamine","volume":"81","author":"Lener","year":"2017","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116697_bib0068","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/nyas.12742","article-title":"Rhythms and blues: modulation of oscillatory synchrony and the mechanism of action of antidepressant treatments","volume":"1344","author":"Leuchter","year":"2015","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.psychres.2025.116697_bib0069","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13293-021-00402-2","article-title":"Sex differences in the expression of the endocannabinoid system within V1M cortex and PAG of Sprague Dawley rats","volume":"12","author":"Levine","year":"2021","journal-title":"Biol. Sex. Differ."},{"key":"10.1016\/j.psychres.2025.116697_bib0070","doi-asserted-by":"crossref","first-page":"223","DOI":"10.5498\/wjp.v10.i10.223","article-title":"Mechanisms of repetitive transcranial magnetic stimulation for anti-depression: evidence from preclinical studies","volume":"10","author":"Luan","year":"2020","journal-title":"World J. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116697_bib0071","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajp.2020.101983","article-title":"Brain-derived neurotrophic factor blood levels after electroconvulsive therapy in patients with major depressive disorder: a systematic review and meta-analysis","volume":"51","author":"Luan","year":"2020","journal-title":"Asian J. Psychiatry."},{"key":"10.1016\/j.psychres.2025.116697_bib0072","doi-asserted-by":"crossref","first-page":"207","DOI":"10.31887\/DCNS.2020.22.3\/blutz","article-title":"Neurobiology of cannabinoid receptor signaling","volume":"22","author":"Lutz","year":"2020","journal-title":"Dialogues. Clin. Neurosci."},{"key":"10.1016\/j.psychres.2025.116697_bib0073","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112845","article-title":"Metabolomics and integrated network analysis reveal roles of endocannabinoids and large neutral amino acid balance in the ayahuasca experience","volume":"149","author":"Madrid-Gambin","year":"2022","journal-title":"Biomed. PharmacOther"},{"issue":"2","key":"10.1016\/j.psychres.2025.116697_bib0074","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyae064","article-title":"A novel insight into the antidepressant effect of cannabidiol: possible involvement of the 5-HT1A, CB1, GPR55, and ppar\u03b3 receptors","volume":"28","author":"Miao","year":"2025","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.psychres.2025.116697_bib0075","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.euroneuro.2024.11.007","article-title":"Cannabis use and psychosis: evidence and new clinical features of a new epidemic","volume":"91","author":"Martinotti","year":"2025","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.psychres.2025.116697_bib0076","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.jad.2022.09.043","article-title":"Real-world experience of esketamine use to manage treatment-resistant depression: a multicentric study on safety and effectiveness (REAL-ESK study)","volume":"319","author":"Martinotti","year":"2022","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psychres.2025.116697_bib0077","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/346561a0","article-title":"Structure of a cannabinoid receptor and functional expression of the cloned cDNA","volume":"346","author":"Matsuda","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.psychres.2025.116697_bib0078","doi-asserted-by":"crossref","unstructured":"McIntyre, R.S., Alsuwaidan, M., Baune, B.T., Berk, M., Demyttenaere, K., Goldberg, J.F., Gorwood, P., Ho, R., Kasper, S., Kennedy, S.H., Ly-Uson, J., Mansur, R.B., McAllister-Williams, R.H., Murrough, J.W., Nemeroff, C.B., Nierenberg, A.A., Rosenblat, J.D., Sanacora, G., Schatzberg, A.F., Shelton, R., Stahl, S.M., Trivedi, M.H., Vieta, E., Vinberg, M., Williams, N., Young, A.H., Maj, M., 2023. Treatment-resistant depression: definition, prevalence, detection, management, and investigational interventions. World Psychiatry. 22, 394\u2013412. https:\/\/doi.org\/10.1002\/wps.21120.","DOI":"10.1002\/wps.21120"},{"key":"10.1016\/j.psychres.2025.116697_bib0079","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2114549118","article-title":"Theta activity paradoxically boosts gamma and ripple frequency sensitivity in prefrontal interneurons","volume":"118","author":"Merino","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.psychres.2025.116697_bib0080","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/npp.2017.143","article-title":"The role of the endocannabinoid system and genetic variation in adolescent brain development","volume":"43","author":"Meyer","year":"2018","journal-title":"Neuropsychopharmacol"},{"key":"10.1016\/j.psychres.2025.116697_bib0081","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.pharmthera.2012.12.002","article-title":"Endocannabinoid system and mood disorders: priming a target for new therapies","volume":"138","author":"Micale","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.psychres.2025.116697_bib0082","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174417","article-title":"Activation of VTA\/CeA\/mPFC cannabinoid CB1 receptors induced conditioned drug effects via interacting with hippocampal CAMKII-CREB-BDNF signaling pathway in rats","volume":"909","author":"Navabpour","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.psychres.2025.116697_bib0083","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231810254","article-title":"Dynamic changes in the endocannabinoid system during the aging process: focus on the middle-age crisis","volume":"23","author":"Nidadavolu","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.psychres.2025.116697_bib0084","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ijpsycho.2018.07.004","article-title":"Enhanced theta-gamma coupling associated with hippocampal volume increase following high-frequency left prefrontal repetitive transcranial magnetic stimulation in patients with major depression","volume":"133","author":"Noda","year":"2018","journal-title":"Int. J. Psychophysiol."},{"key":"10.1016\/j.psychres.2025.116697_bib0085","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.clinph.2016.12.023","article-title":"Resting-state EEG gamma power and theta\u2013gamma coupling enhancement following high-frequency left dorsolateral prefrontal rTMS in patients with depression","volume":"128","author":"Noda","year":"2017","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.psychres.2025.116697_bib0086","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/da.22738","article-title":"Impaired neuroplasticity in the prefrontal cortex in depression indexed through paired associative stimulation","volume":"35","author":"Noda","year":"2018","journal-title":"Depress. Anxiety."},{"key":"10.1016\/j.psychres.2025.116697_bib0087","doi-asserted-by":"crossref","first-page":"760","DOI":"10.2174\/1570159X13666150612225212","article-title":"Inhibitors of fatty acid amide hydrolase and monoacylglycerol lipase: new targets for future antidepressants","volume":"13","author":"Ogawa","year":"2015","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.psychres.2025.116697_bib0088","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.neulet.2019.01.059","article-title":"Ketamine induces central antinociception mediated by endogenous cannabinoids and activation of CB1 receptors","volume":"699","author":"Pacheco","year":"2019","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.psychres.2025.116697_bib0089","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1017\/S0033291718001356","article-title":"Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial","volume":"49","author":"Palhano-Fontes","year":"2019","journal-title":"Psychol. Med."},{"issue":"12","key":"10.1016\/j.psychres.2025.116697_bib0090","first-page":"1","article-title":"Cannabinoid CB1 receptor agonists produce opposing effects on anxiety depending on dose and context","volume":"5","author":"Patel","year":"2001","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.psychres.2025.116697_bib0091","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0088672","article-title":"Endocannabinoid modulation of cortical up-states and NREM sleep","volume":"9","author":"Pava","year":"2014","journal-title":"PLoS. One"},{"key":"10.1016\/j.psychres.2025.116697_bib0092","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jad.2023.03.066","article-title":"High-frequency repetitive transcranial magnetic stimulation regulates neural oscillations of the hippocampus and prefrontal cortex in mice by modulating endocannabinoid signalling","volume":"331","author":"Peng","year":"2023","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psychres.2025.116697_bib0093","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2023.115378","article-title":"Predicting outcome with Intranasal Esketamine treatment: a machine-learning, three-month study in Treatment-Resistant Depression (ESK-LEARNING)","volume":"327","author":"Pettorruso","year":"2023","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psychres.2025.116697_bib0094","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s11033-019-05129-3","article-title":"The cellular and molecular basis of major depressive disorder: towards a unified model for understanding clinical depression","volume":"47","author":"Pitsillou","year":"2020","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.psychres.2025.116697_bib0095","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1038\/npp.2013.126","article-title":"Neuroplasticity in depressed individuals compared with healthy controls","volume":"38","author":"Player","year":"2013","journal-title":"Neuropsychopharmacol"},{"key":"10.1016\/j.psychres.2025.116697_bib0096","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.brainresbull.2019.05.021","article-title":"Influence of the CB1 cannabinoid receptors on the activity of the monoaminergic system in the behavioural tests in mice","volume":"150","author":"Poleszak","year":"2019","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.psychres.2025.116697_bib0097","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1007\/s43440-020-00088-0","article-title":"Influence of the endocannabinoid system on the antidepressant activity of bupropion and moclobemide in the behavioural tests in mice","volume":"72","author":"Poleszak","year":"2020","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.psychres.2025.116697_bib0098","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2023.114502","article-title":"The chronic pharmacological antagonism of the CB1 receptor is not involved in the behavioral effects of antidepressants administered in mice submitted to chronic unpredictable stress","volume":"450","author":"Ribeiro","year":"2023","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.psychres.2025.116697_bib0099","doi-asserted-by":"crossref","first-page":"612","DOI":"10.2174\/011570159X337670241029062524","article-title":"Esketamine treatment trajectory of patients with treatment-resistant depression in the mid and long-term run: data from REAL-ESK study group","volume":"23","author":"Rosso","year":"2025","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.psychres.2025.116697_bib0101","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1007\/s00018-018-2994-6","article-title":"Multiple endocannabinoid-mediated mechanisms in the regulation of energy homeostasis in brain and peripheral tissues","volume":"76","author":"Ruiz De Azua","year":"2019","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.psychres.2025.116697_bib0102","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12888-019-2409-8","article-title":"Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review","volume":"20","author":"Sarris","year":"2020","journal-title":"BMC. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116697_bib0103","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.neuroscience.2010.04.007","article-title":"Social isolation and chronic handling alter endocannabinoid signaling and behavioral reactivity to context in adult rats","volume":"168","author":"Sciolino","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.psychres.2025.116697_bib0104","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104635","article-title":"Rapid treatments for depression: endocannabinoid system as a therapeutic target","volume":"137","author":"Sharafi","year":"2022","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.psychres.2025.116697_bib0105","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1111\/ejn.13800","article-title":"Cannabinoid\u2013glutamate interactions and neural oscillations: implications for psychosis","volume":"48","author":"Sherif","year":"2018","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.psychres.2025.116697_bib0106","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.euroneuro.2020.09.633","article-title":"Value of peripheral neurotrophin levels for the diagnosis of depression and response to treatment: a systematic review and meta-analysis","volume":"41","author":"Shi","year":"2020","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.psychres.2025.116697_bib0107","doi-asserted-by":"crossref","first-page":"181","DOI":"10.30773\/pi.2019.0236","article-title":"Ketamine in major depressive disorder: mechanisms and future perspectives","volume":"17","author":"Shin","year":"2020","journal-title":"Psychiatry Investig."},{"key":"10.1016\/j.psychres.2025.116697_bib0108","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107545","article-title":"Modulation of the endocannabinoid system by (S)-ketamine in an animal model of depression","volume":"211","author":"Silva","year":"2025","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.psychres.2025.116697_bib0109","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0089432","article-title":"Multiple sleep alterations in mice lacking cannabinoid type 1 receptors","volume":"9","author":"Silvani","year":"2014","journal-title":"PLoS. One"},{"key":"10.1016\/j.psychres.2025.116697_bib0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115261","article-title":"Biosynthesis and metabolism of endocannabinoids and their congeners from the monoacylglycerol and N-acyl-ethanolamine families","volume":"205","author":"Simard","year":"2022","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.psychres.2025.116697_bib0111","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.biopsych.2015.12.011","article-title":"It\u2019s all in the rhythm: the role of cannabinoids in neural oscillations and psychosis","volume":"79","author":"Skosnik","year":"2016","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116697_bib0112","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s12640-014-9465-0","article-title":"Antidepressants and changes in concentration of endocannabinoids and n-acylethanolamines in rat brain structures","volume":"26","author":"Smaga","year":"2014","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.psychres.2025.116697_bib0114","doi-asserted-by":"crossref","first-page":"241","DOI":"10.31887\/DCNS.2020.22.3\/rspanagel","article-title":"Cannabinoids and the endocannabinoid system in reward processing and addiction: from mechanisms to interventions","volume":"22","author":"Spanagel","year":"2020","journal-title":"Dialogues. Clin. Neurosci."},{"key":"10.1016\/j.psychres.2025.116697_bib0115","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.pbb.2008.05.010","article-title":"Cannabinoid receptors 1 and 2 (CB1 and CB2), their distribution, ligands and functional involvement in nervous system structures \u2014 A short review","volume":"90","author":"Svizenska","year":"2008","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.psychres.2025.116697_bib0116","doi-asserted-by":"crossref","first-page":"7958","DOI":"10.1523\/JNEUROSCI.0247-14.2014","article-title":"Presynaptic calcium channel inhibition underlies cb1 cannabinoid receptor-mediated suppression of GABA release","volume":"34","author":"Szab\u00f2","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.psychres.2025.116697_bib0117","doi-asserted-by":"crossref","first-page":"6253","DOI":"10.3390\/jcm13206253","article-title":"Evaluating anesthesia practices, patient characteristics, and outcomes in electroconvulsive therapy: a two-year retrospective study","volume":"13","author":"Vintil\u0103","year":"2024","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.psychres.2025.116697_bib0118","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cell.2021.12.003","article-title":"BDNF signaling in context: from synaptic regulation to psychiatric disorders","volume":"185","author":"Wang","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.psychres.2025.116697_bib0119","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jpsychires.2014.01.004","article-title":"Anti-depressive mechanism of repetitive transcranial magnetic stimulation in rat: the role of the endocannabinoid system","volume":"51","author":"Wang","year":"2014","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.psychres.2025.116697_bib0120","doi-asserted-by":"crossref","first-page":"11044","DOI":"10.1523\/JNEUROSCI.2125-11.2011","article-title":"Repetitive transcranial magnetic stimulation enhances BDNF-TrkB signaling in both brain and lymphocyte","volume":"31","author":"Wang","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.psychres.2025.116697_bib0121","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2024.111243","article-title":"Early psilocybin intervention alleviates behavioral despair and cognitive impairment in stressed Wistar rats","volume":"136","author":"Wang","year":"2025","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116697_bib0122","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ynstr.2016.08.002","article-title":"The chronic mild stress (CMS) model of depression: history, evaluation and usage","volume":"6","author":"Willner","year":"2017","journal-title":"Neurobiol. Stress."},{"key":"10.1016\/j.psychres.2025.116697_bib0124","doi-asserted-by":"crossref","first-page":"5962","DOI":"10.1038\/s41467-020-19780-z","article-title":"Endocannabinoid signaling regulates the reinforcing and psychostimulant effects of ketamine in mice","volume":"11","author":"Xu","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.psychres.2025.116697_bib0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2019.172738","article-title":"Repetitive high-frequency transcranial magnetic stimulation reverses depressive-like behaviors and protein expression at hippocampal synapses in chronic unpredictable stress-treated rats by enhancing endocannabinoid signaling","volume":"184","author":"Xue","year":"2019","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.psychres.2025.116697_bib0126","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2021.113162","article-title":"The role of pro- and mature neurotrophins in the depression","volume":"404","author":"Xue","year":"2021","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.psychres.2025.116697_bib0128","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2021.113917","article-title":"Inhibition of CB1 receptor alleviates electroconvulsive shock-induced memory impairment by regulating hippocampal synaptic plasticity in depressive rats","volume":"300","author":"Yu","year":"2021","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psychres.2025.116697_bib0129","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.117.015198","article-title":"Ketamine and ketamine metabolite pharmacology: insights into therapeutic mechanisms","volume":"70","author":"Zanos","year":"2018","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.psychres.2025.116697_bib0130","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1002\/jnr.22580","article-title":"Requirement for the endocannabinoid system in social interaction impairment induced by coactivation of dopamine D1 and D2 receptors in the piriform cortex","volume":"89","author":"Zenko","year":"2011","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.psychres.2025.116697_bib0131","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0029-14.2015","article-title":"Role for endogenous BDNF in endocannabinoid-mediated long-term depression at neocortical inhibitory synapses","volume":"2","author":"Zhao","year":"2015","journal-title":"eNeuro"},{"key":"10.1016\/j.psychres.2025.116697_bib0132","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.neuroscience.2015.01.071","article-title":"Synaptic plasticity-related neural oscillations on hippocampus\u2013prefrontal cortex pathway in depression","volume":"292","author":"Zheng","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.psychres.2025.116697_bib0133","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s11571-012-9225-x","article-title":"Alteration of phase\u2013phase coupling between theta and gamma rhythms in a depression-model of rats","volume":"7","author":"Zheng","year":"2013","journal-title":"Cogn. Neurodyn."},{"key":"10.1016\/j.psychres.2025.116697_bib0134","doi-asserted-by":"crossref","first-page":"435","DOI":"10.31083\/ph.2017.7474","article-title":"Role of the endocannabinoid system in the formation and development of depression","volume":"72","author":"Zhou","year":"2017","journal-title":"Pharmazie"},{"key":"10.1016\/j.psychres.2025.116697_bib0135","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3390\/ijms19030833","article-title":"Cannabinoid receptors and the endocannabinoid system: signaling and function in the Central nervous system","volume":"19","author":"Zou","year":"2018","journal-title":"Int. J. Mol. Sci."}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178125003440?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178125003440?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T04:40:32Z","timestamp":1779943232000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178125003440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":129,"alternative-id":["S0165178125003440"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2025.116697","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endocannabinoids, depression, and treatment resistance: Perspectives on effective therapeutic interventions","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2025.116697","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"116697"}}